APEX MOLECULAR LIMITED Financials
- Company number
- 06596885Copy
Copy - Registered office
- Block 19 Alderley Park, Mereside, Alderley Edge, Cheshire SK10 4TG
- Incorporated
- 19/05/2008
Company snapshot
- Status
- Active
- Employees
- 0 (2026)
- Latest financial data
- 2026
- Accounts type
- Small
Financial highlights
Latest reported figures. Okredo holds filed data for 2022–2026.
Net Assets
-43.71%vs 20252025: £1.07M
Total Assets
-40.94%vs 20252025: £1.32M
Cash in Bank
-24.33%vs 20252025: £793.01K
Total Liabilities
-28.91%vs 20252025: £246.96K
Employees
0vs 20252025: 0
In 2026, APEX MOLECULAR LIMITED reported net assets of £601.96K. The same filing shows total assets of £777.51K, cash in bank of £600.09K and total liabilities of £175.55K. Reported headcount was 0 in 2026. Total Assets fell from £1.32M in 2025 to £777.51K in 2026 (-40.94%). Okredo holds filed figures for 2022–2026; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
-43.71%from £1.07M in 2025Year-on-year change
Net Assets as filed for 2022–2026. Every figure in this chart is also in the financial history table.
3-year financial trend (2024–2026)
How the figures APEX MOLECULAR LIMITED filed moved across the three reported years 2024, 2025 and 2026 — measured end to end rather than year on year.
Net Assets
-63.4%vs 2024-39.5% a year compound (CAGR)
Cash in Bank
-51.5%vs 2024-30.3% a year compound (CAGR)
Total Assets
-61.9%vs 2024-38.3% a year compound (CAGR)
Total Liabilities
-55.9%vs 2024-33.6% a year compound (CAGR)
Employees
-100%vs 2024-38Biggest decrease
Employees-100%
38 in 2024 to 0 in 2026
Every indicator Okredo holds for APEX MOLECULAR LIMITED fell between 2024 and 2026. The steepest fall came in employee numbers, pointing to a smaller workforce, with net assets, cash in bank, total assets and total liabilities falling alongside it. See the full year-by-year figures.
Ratios from the filed figures
Calculated from APEX MOLECULAR LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 77.42%2026
- Liabilities to total assets
- 22.58%2026
- Cash to liabilities
- 341.83%2026
- Cash to total assets
- 77.18%2026
Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for APEX MOLECULAR LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Assets£ | 1.35M | 1.77M | 1.64M | 1.07M | 601.96K |
| Total Assets£ | 2.29M | 2.36M | 2.04M | 1.32M | 777.51K |
| Cash in Bank£ | 1.30M | 1.41M | 1.24M | 793.01K | 600.09K |
| Total Liabilities£ | 943.09K | 591.28K | 397.85K | 246.96K | 175.55K |
| Employees | 38 | 47 | 38 | 0 | 0 |
APEX MOLECULAR LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Has APEX MOLECULAR LIMITED filed financial statements?
Yes. Okredo holds filed figures for APEX MOLECULAR LIMITED covering 2022–2026, across 5 reported indicators. The most recent reported year is 2026.
What net assets did APEX MOLECULAR LIMITED report in 2026?
APEX MOLECULAR LIMITED reported net assets of £601.96K for 2026. That compares with £1.07M in 2025, a change of -43.71%.
What total assets did APEX MOLECULAR LIMITED report in 2026?
APEX MOLECULAR LIMITED reported total assets of £777.51K for 2026. That compares with £1.32M in 2025, a change of -40.94%.
What cash in bank did APEX MOLECULAR LIMITED report in 2026?
APEX MOLECULAR LIMITED reported cash in bank of £600.09K for 2026. That compares with £793.01K in 2025, a change of -24.33%.
How many people does APEX MOLECULAR LIMITED employ?
APEX MOLECULAR LIMITED reported 0 employees in 2026, compared with 0 in 2025.
How have APEX MOLECULAR LIMITED financials changed over the last 3 years?
Between 2024 and 2026, APEX MOLECULAR LIMITED's net assets fell by 63.4%, cash in bank fell by 51.5%, total assets fell by 61.9% and total liabilities fell by 55.9%. Net assets contracted at 39.5% a year across the two years to 2026, from £1.64M to £601.96K. Reported headcount went from 38 in 2024 to 0 in 2026 (-38).
Which years of APEX MOLECULAR LIMITED financial data are available?
Okredo holds reported figures for the years 2022, 2023, 2024, 2025, 2026. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.